• High Accuracy, Specificity and Sensitivity
• Test results within 20 minutes
• 12 Months Shelf Life
• Room Temperature Storage
• Nasal Swabs or Throat Swabs available
• Easy to operate and requires no additional equipment
The nasal swabs:
Relative Sensitivity: 97.5%
Relative Specificity: 99.2%
The oral and saliva swabs:
Relative Sensitivity: 95.8%
Relative Specificity:: 98.4%
CAS-Envision SARS-CoV-2 Antigen Rapid Detection Kit is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal or throat swab specimen.
The test provides preliminary test results but cannot be used as the sole basis for treatment or other management decision.Positive results indicate the presence of viral antigens,but do not rule out bacterial infection or co-infection with other viruses.Negative results do not rule out SARS-CoV-2 infection.The results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary for patient management.
The test is intended for use by professionals only,and the test results must be interpreted by professionals.
This reagent is based on colloidal gold immunochromatography assay. During the test, specimen extracts are applied to the test cartridges. If there were SARS-CoV-2 antigen in the extract, the antigen will bind to the SARS-CoV-2 monoclonal antibody. During lateral flow, the complex will move along the nitrocellulose membrane toward the end of the absorbent paper. When passing the test line (line T, coated with another SARS-CoV-2 monoclonal antibody) the complex is captured by SARS-CoV-2 antibody on test line resulting in coloring on line T; when passing the line C, colloidal gold-labeled goat anti-rabbit IgG is captured by control line (line C, coated with rabbit IgG) resulting in coloring on line C.
Declaration of Conformity
EU Health Preparedness Common List of Rapid Antigen Tests